111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-5.44%
Revenue decline while JHX shows 10.24% growth. Joel Greenblatt would examine competitive position erosion.
No Data
No Data available this quarter, please select a different quarter.
29.84%
Gross profit growth 1.25-1.5x JHX's 25.44%. Bruce Berkowitz would examine sustainability.
37.32%
Margin expansion exceeding 1.5x JHX's 13.78%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-323.49%
EBITDA decline while JHX shows 76.90% growth. Joel Greenblatt would examine position.
-336.35%
EBITDA margin decline while JHX shows 135.18% growth. Joel Greenblatt would examine position.
-323.49%
Operating income decline while JHX shows 93.99% growth. Joel Greenblatt would examine position.
-336.35%
Operating margin decline while JHX shows 75.97% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.36%
Tax expense growth less than half of JHX's 35.61%. David Dodd would verify if advantage is sustainable.
-4.36%
Net income decline while JHX shows 137.44% growth. Joel Greenblatt would examine position.
1.15%
Net margin growth below 50% of JHX's 115.37%. Michael Burry would check for structural issues.
23646.15%
EPS growth exceeding 1.5x JHX's 1650.00%. David Dodd would verify competitive advantages.
23455.13%
Diluted EPS growth exceeding 1.5x JHX's 1650.00%. David Dodd would verify competitive advantages.
-100.00%
Share count reduction while JHX shows 0.00% change. Joel Greenblatt would examine strategy.
-100.00%
Both companies reducing diluted shares. Martin Whitman would check patterns.